Multinational cannabis operator Ikänik Farms, Inc. (CSE: IKNK.U) (FSE: DFMA) is getting ready to send its South America-grown cannabis to other countries.
On Thursday, the Toronto-headquarter company with primary operations in Colombia announced its subsidiary Pideka SAS based in Bogota, has received European Union Good Manufacturing Practices (EU GMP) by the chief pharmaceutical inspectorate in Poland, Główny Inspektor Farmaceutyczny (GIF).
The company received the certification for its indoor cannabis manufacturing operation and processing protocols of dried flower as an Active Pharmaceutical Ingredient (API) for manufacturing pharmaceutical products.
The certification allows Pideka to export pharma-grade THC dried flower and its derivatives to distributors and importers in Europe and other international markets.
Borja Sanz De Madrid, interim CEO at Ikänik Farms said the certification recognizes Pideka as meeting the quality standards and production, handling, storage and packaging guidelines for psychoactive flower.
He explained its regulatory, operation and quality control teams spent two and half years working with the Polish inspectors preparing and submitting the licensing dossiers and completing the valuations and audits.
According to Sanz de Madrid, Pideka is the only indoor THC cultivation facility in Latin America to have received the certification.
Pideka wants to quickly ramp up its annual production to 10.8 tons of psychoactive dried flower and secure further sales contracts from leading global cannabis operators.
Company stock remained flat Thursday at $0.035 on the Canadian Securities Exchange.